Oligomenorrhea

Oligomenorrhea
Other namesOligomenorrhoea
SpecialtyGynecology

Oligomenorrhea is an abnormal bleeding pattern where menstrual bleeding occurs at intervals of greater than 35 days, with fewer than 9 periods in a year.[1] The period may be light in flow, short in duration or occur at irregular intervals.[1] Oligomenorrhea is common in adolescent females in the first few years following menarche.[2]

Causes of oligomenorrhea range from chromosomal abnormalities to hypothalamic-pituitary conditions to hormonal imbalances. A common cause of oligomenorrhea is polycystic ovary syndrome (PCOS), a hormonal imbalance that results in menstrual irregularity.[3]

Menarche

Menarche is the first menstrual bleed in a female that has reached reproductive age. The median age at menarche is "12-13 years old across well-nourished populations in developed countries".[2] While the timing of pubertal development may vary among individuals, the order in which it occurs is fairly standard. Puberty in females begins with thelarche (breast development) followed by pubarche (growth of pubic and axillary hair) then followed, typically within 2-3 years of thelarche, by menarche. During adolescence, menstrual cycle intervals and durations may vary while the hypothalamic-pituitary-ovarian axis begins to mature.[2] Anovulation during the first few years of menstruation after menarche can cause variation in cycle intervals. A normal menstrual cycle typically lasts between 21-35 days.[3]

Causes

Premature ovarian insufficiency (POI), also known as primary ovarian insufficiency, is defined as "menopause before the age of 40" and presents as a "spectrum of declining ovarian function" resulting in reduced fertility due to a decrease in ovarian follicle number.[4][5] While majority of cases of POI are idiopathic, chromosomal abnormalities that result in the damage or loss of the X chromosome (i.e. Turner Syndrome, FMR1 pre-mutation carriers) have been described to reduce ovarian functionality and lead to premature ovarian insufficiency.[5] Other causes of POI include autoimmune disorders, chemotherapy, and pelvic radiation which cause rapid ovarian destruction and follicular depletion.[6] In those experiencing oligomenorrhea or menstrual irregularity, a diagnosis of POI can be confirmed with two elevated follicle-stimulating hormone levels (greater than 30-40 mIU/mL) at least 1 month apart.[6]

While primary amenorrhea is most common among those with Turner Syndrome, oligomenorrhea can be a symptom that these individuals experience.[7] Turner Syndrome is a chromosomal disorder where individuals have complete or partial loss of a single X chromosome, with the most common karyotype being 45,XO. Typical physical characteristics of Turner Syndrome include a webbed neck, low hairline, short stature, broad chest, and congenital heart defects. Irregular or absent menstrual cycles can occur with this condition as a result of streak ovaries or gonadal dysgenesis. It has been found that in individuals with Turner Syndrome "oocyte apoptosis is markedly accelerated in the early stage of fetal life," leading to low ovarian reserve and menstrual abnormalities.[8] Many of these individuals are often first diagnosed when evaluated for menstrual irregularities.[9]

People with polycystic ovary syndrome (PCOS) are also likely to have oligomenorrhea. Polycystic ovary syndrome (PCOS) is a hormone disorder that is characterized by hyperandrogenism, polycystic ovaries, and menstrual irregularity. While there is no universally recognized definition of PCOS, all diagnostic schema require presence of at least two of the defining characteristics.[10] Clinical signs of hyperandrogenism can include hirsutism, acne, acanthosis, virilization (deepening of the voice, male-pattern balding), weight gain, and menstrual abnormalities.[11] Menstrual irregularity and infertility are common clinical manifestations of PCOS where individuals may experience infrequent periods, absent periods, or heavy and unpredictable cycles.[12] As a result of hormone imbalance and chronic anovluation, individuals with PCOS can develop endometrial hyperplasia which can in-turn increase the risk of endometrial cancer.[12] PCOS is often associated with insulin resistance and obesity, conditions that increase the risk for chronic diseases such as type 2 diabetes and cardiovascular disease. Weight loss in those with PCOS has been shown to improve insulin resistance, decrease circulating androgen levels, and restore ovarian function. [13] The use of combined hormonal birth control pills has been shown to help regulate menstrual cycles and decrease the risk of endometrial cancer.[12]

Functional hypothalamic amenorrhea

Eating disorders can result in oligomenorrhea. Although menstrual disorders are most strongly associated with anorexia nervosa, bulimia nervosa may also result in oligomenorrhea or amenorrhea. There is some controversy regarding the mechanism for the menstrual dysregulation, since amenorrhea may sometimes precede substantial weight loss in some anorexics. Endurance exercises such as running or swimming can affect the reproductive physiology of female athletes. Female runners,[14][15] swimmers[16] and ballet dancers[17] either menstruate infrequently in comparison to non-athletic females of comparable age or exhibit amenorrhea. A more recent study shows that athletes competing in sports that emphasize thinness or a specific weight exhibit a higher rate of menstrual dysfunction than either athletes competing in sports with less focus on these or control subjects.[18]

Oligomenorrhea can be a result of other various causes including prolactinomas (adenomas of the anterior pituitary), thyrotoxicosis, hormonal changes in perimenopause, Prader–Willi syndrome, and Graves' disease, certain medications, and breastfeeding.

Amenorrhea

Amenorrhea can be defined as a complete absence of menses. Amenorrhea can be divided into two categories: primary and secondary amenorrhea. Primary amenorrhea occurs when no menses occurs by the age of 15 with or without evidence of secondary sexual characteristics, or if no menses occur within three years of thelarche.[3] The causes of amenorrhea overlap with the causes of oligomenorrhea, with oligomenorrhea being a potential prodrome of amenorrhea.

See also

References

  1. ^ a b Riaz, Yumna; Parekh, Utsav (2023). "Oligomenorrhea". StatPearls. StatPearls Publishing. PMID 32809410.
  2. ^ a b c "Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign". www.acog.org. Retrieved 2026-03-10.
  3. ^ a b c Klein, David A.; Poth, Merrily A. (2013-06-01). "Amenorrhea: An Approach to Diagnosis and Management". American Family Physician. 87 (11): 781–788.
  4. ^ Nash, Zachary; Davies, Melanie (2024-03-20). "Premature ovarian insufficiency". BMJ. 384 e077469. doi:10.1136/bmj-2023-077469. ISSN 1756-1833. PMID 38508679.
  5. ^ a b "Hormone Therapy in Primary Ovarian Insufficiency". www.acog.org. Retrieved 2026-03-14.
  6. ^ a b "Committee Opinion No. 605: Primary Ovarian Insufficiency in Adolescents and Young Women". Obstetrics & Gynecology. 124 (1): 193–197. July 2014. doi:10.1097/01.AOG.0000451757.51964.98. ISSN 0029-7844.
  7. ^ Essouabni, Amal; Ahakoud, Mohamed; Aynaou, Hayat; Bouguenouch, Laila; Salhi, Houda; Karim, Ouldim; Elouahabi, Hanan (June 2023). "Rare and Atypical Case of Turner Syndrome With Three Cell Lines". Cureus. 15 (6) e41128. doi:10.7759/cureus.41128. ISSN 2168-8184. PMC 10385896. PMID 37519544.
  8. ^ Fukami, Maki (2023). "Ovarian dysfunction in women with Turner syndrome". Frontiers in Endocrinology. 14 1160258. doi:10.3389/fendo.2023.1160258. ISSN 1664-2392. PMC 10076527. PMID 37033245.
  9. ^ "Primary Ovarian Insufficiency in Adolescents and Young Women". www.acog.org. Retrieved 2026-03-12.
  10. ^ "Polycystic Ovary Syndrome". www.acog.org. Retrieved 2026-03-22.
  11. ^ "Screening and Management of the Hyperandrogenic Adolescent". www.acog.org. Retrieved 2026-03-22.
  12. ^ a b c "Polycystic Ovary Syndrome (PCOS)". www.acog.org. Retrieved 2026-03-22.
  13. ^ Clark, A. M.; Thornley, B.; Tomlinson, L.; Galletley, C.; Norman, R. J. (1998-06-01). "Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment". Human Reproduction. 13 (6): 1502–1505. doi:10.1093/humrep/13.6.1502. ISSN 0268-1161.
  14. ^ Dale E, Gerlach DH, Wilhite AL (1979). "Menstrual dysfunction in distance runners". Obstet Gynecol. 54 (1): 47–53. doi:10.1097/00006250-197907000-00013. PMID 313033.
  15. ^ Wakat DK, Sweeney KA, Rogol AD (1982). "Reproductive system function in women cross-country runners". Med Sci Sports Exerc. 14 (4): 263–9. doi:10.1249/00005768-198204000-00002. PMID 7132642.
  16. ^ Frisch RE, Gotz-Welbergen AV, McArthur JW, et al. (1981). "Delayed menarche and amenorrhea of college athletes in relation to age of onset of training". JAMA. 246 (14): 1559–1563. doi:10.1001/jama.246.14.1559. PMID 7277629.
  17. ^ Warren MP (1980). "The effects of exercise on pubertal progression and reproductive function in girls". J. Clin. Endocrinol. Metab. 51 (5): 1150–1157. doi:10.1210/jcem-51-5-1150. PMID 6775000.
  18. ^ Torsiveit, MK (2005). "Participation in leanness sports but not training volume is associated with menstrual dysfunction: a national survey of 1276 elite athletes and controls". British Journal of Sports Medicine. 39 (3): 141–147. doi:10.1136/bjsm.2003.011338. PMC 1725151. PMID 15728691.